BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2026.
Artif Intell Gastroenterol. Jan 8, 2026; 7(1): 115498
Published online Jan 8, 2026. doi: 10.35712/aig.v7.i1.115498
Table 1 Application of multimodal data in gastrointestinal tumors
Data type
Core characteristics and key technologies
Main clinical application scenarios
AI empowerment and value
Imaging dataCT: High spatial resolution, rapid imaging, morphological analysis; MRI: Excellent soft tissue contrast (DWI, DCE), microenvironment assessment; PET: High metabolic sensitivity (SUV value), assessment of biological activityTumor localization, staging, efficacy evaluation, recurrence monitoringAI application: Automatic segmentation based on CNN; radiomics feature mining. Value: Improves diagnostic consistency, predicts efficacy and metastasis risk
Endoscopic dataProvides HD real-time visualization of mucosal layer; chromo/electronic staining enhances contrastEarly screening and diagnosis (e.g., early gastric cancer, colorectal polyp detection)AI Application: CNN models for automatic lesion identification, classification, and depth assessment. Value: Increases early detection rate, assists treatment decisions
Omics dataGenomics: Reveals driver mutations (e.g., HER2). Transcriptomics/proteomics/metabolomics: Reflects gene expression, protein function, metabolic statusDeciphering tumor heterogeneity, predicting treatment response and prognosis, facilitating personalized therapyAI Application: Feature selection and dimension reduction; multimodal fusion (e.g., GNN model StereoMM, drug response prediction model DROEG). Value: Mines molecular mechanisms, enables precise typing, predicts drug sensitivity


Write to the Help Desk